In contrast to those in MDS or UM, SF3B1 mutations that are cancer-related occur more commonly in advanced disease and tend to be associated with poor prognosis in other malignancies, including CLL. Here, SF3B1 is linked to B-cell chronic lymphocytic leukemia.